XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.4
UNAUDITED CONDENSED INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
3 Months Ended
Oct. 31, 2020
Oct. 31, 2019
Income Statement [Abstract]    
Revenue $ 88,435 $ 721,661
Cost of Goods Sold 23,333 133,618
Gross profit 65,102 588,043
Operating expenses    
Research and development 1,170,008 338,734
Bad debt expense 0 10,981
General and administrative 13,008,172 4,787,039
Total operating expenses 14,178,080 5,316,754
Operating Loss (14,113,078) (4,548,711)
Other Income (Expense):    
Interest expense (1,019,080) (2,516,113)
Interest income 0 452
Change in fair value of common stock payable 123,230 0
Change in fair value of derivative liability 4,019,852 (2,239,422)
Other income, net 0 (8,753)
Net loss (10,989,076) (9,312,547)
Net loss attributable to noncontrolling interests (258,384) (186,602)
Net loss available to common stockholders $ (10,730,692) $ (9,125,945)
Basic $ (0.11) $ (0.13)
Diluted $ (0.11) $ (0.13)
Basic 96,859,079 69,800,583
Diluted 96,859,079 69,800,583
Comprehensive loss    
Net loss available to common stockholders $ (10,730,692) $ (9,125,945)
Change in foreign currency translation adjustments (2,202) (294)
Comprehensive loss available to common stockholders $ (10,732,894) $ (9,126,239)